Gonadorelin Injection

For use in oestrus synchronization programs in combination with PGF2α. For the treatment of cystic ovaries, prevention of delayed ovulation and improvement of postpartum fertility in cattle. 

Size: 20 mL and 100 mL vial 

Dosage and Administration

Discard all open vials 28 days after broaching. 

Cattle: Injection to be given into the anterior half of the neck. 

Cystic ovaries: 5 mL (500 µg Gonadorelin) by intramuscular injection. 

Prevention of delayed ovulation: 2.5 mL (250 µg Gonadorelin) by intramuscular injection. 

Improvement of postpartum fertility: 2.5 mL (250 µg Gonadorelin) by intramuscular injection.

Oestrus synchronization: 1 mL (100 µg Gonadorelin) per dose intramuscular injection, for example: 

Day 0 1 mL (100 µg Gonadorelin)
Day 7 2 mL PGF2α
Day 9  1 mL (100 µg Gonadorelin)

Insemination 8-24 hours after 2nd elevet+ Gonadorelin Injection.

Active Constituent(s)

100 µg/mL GONADORELIN (as ACETATE)

Indications

1: OESTRUS SYNCHRONISATION 

Oestrus synchronisation protocols involving the use of Prostaglandin F2 (PGF2a) and Gonadotropin Releasing Hormone (GnRH) have been subjected to extensive study in dairy herds around the world. Comparisons have 
been made between GnRH/PGF2a synchronisation programs and a variety of existing reproductive management programs of varying levels of intervention. GnRH/PGF2a protocols have measured favourably against standard prostaglandin programs in terms of reproductive parameters such as pregnancy rate and calving to conception interval. 
Unlike previously implemented synchronisation protocols utilising PGF2a only, application of the GnRH/PGF2a protocol described below results in synchronisation of ovulation to the degree of precision that allows fixed-time insemination. 
A reproductive program using fixed-time insemination provides numerous benefits both in terms of reduced management input and economic advantages. Fixed-time insemination reduces management input through the insemination of large groups of cows together, and by elimination of the need for oestrus detection activities in the first round. The benefits are magnified in situations where the level of oestrus detection is low. Economic benefits of a fixed-time insemination program result from a reduction in calving to conception interval and a tighter calving pattern, parameters of particular significance under seasonal calving conditions. 
GnRH/PGF2a protocols have the added advantage of demonstrated success for simultaneous treatment and synchronisation of cows suffering from cystic ovarian disease, and the ability to stimulate and synchronise the oestrous cycle of previously anovulatory cows. 
The GnRH/PGF2a protocol that has received the most interest and study for its applicability to dairy cattle reproductive management may be summarized as follows: 
Day O GnRH administration 
Day 7 PGF2a administration 
Day 9 GnRH administration 
(48 hours after PGF2a) 
Insemination 8-24 hours after 2nd GnRH. 
Insemination is performed at a fixed time 8 to 24 hours after the 2nd GnRH dose, regardless of the presence or absence of visible oestrus. 
The rationale behind the GPG (Gonadotropin-Prostaglandin-Gonadotropin) protocol is as follows: 

1.    The initial GnRH dose induces either ovulation or luteinisation of the dominant follicle present at the time of treatment, and the smaller follicles undergo atresia. A new follicular wave is subsequently recruited, and a new dominant follicle gradually emerges.
2.    7 days after treatment with GnRH, administration of PGF2a causes luteolysis of the GnRH-induced corpus luteum. The new dominant follicle is ready to ovulate 2-3 days later.
3.    The 2nd GnRH dose induces an LH surge which further synchronises the dominant follicle, resulting in ovulation of predictable timing, allowing fixed-time insemination 8-24 hours later.

GnRH/PGF2a oestrus synchronisation protocols are intended for lactating dairy cattle. 
Variable results are reported in the literature of the application of GnRH/PGF2a in heifers. 

2: PREVENTION OF DELAYED OVULATION 

Delayed ovulation can result in the reduction of the rate of conception due to asynchrony between ova and sperm at the time of artificial insemination (Al). 

Delayed ovulation can be prevented by the administration of elevet+ Gonadorelin Injection, which stimulates the release of LH and hence induces ovulation. 

3: IMPROVEMENT OF POSTPARTUM FERTILITY 

It is important that normal ovarian cyclical activity resume in the early post-partum period to minimise the calving to conception interval or "days open". elevet+ Gonadorelin Injection given in the first 40 days of the postpartum period may initiate the ovarian cyclical activity to resume and reduce the incidence of postpartum infertility in cows. 

4: TREATMENT OF CYSTIC OVARIES 

Cystic ovaries are an infertility problem in dairy cattle, which may be of single or multiple and of follicular or luteal origin. Clinical signs of ovarian cysts include irregular oestrous cycles, anoestrus and nymphomania. Ovarian cysts can be diagnosed by rectal palpation of the structure on one or both ovaries. Treatment of cystic ovaries with elevet+ Gonadorelin Injection may result in the recommencement of normal cyclical activity, through the response of ovarian cysts to the released LH induced by elevet+ Gonadorelin Injection . 

 

 

Related products

Cloprostenol Injection for Cattle & Horses

A luteolytic agent for clinical use and the control of the bovine and equine oestrous ...

Oestradiol Benzoate Injection

To improve the precision of the onset of oestrus and maximise fertility in oestrus ...